期刊
CELL COMMUNICATION AND SIGNALING
卷 21, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12964-022-01032-w
关键词
Resistin-like molecules; Inflammation; Proliferation; Parasite; Lung disease
类别
RELMs are highly cysteine-rich proteins, including RELM alpha, RELM beta, Resistin, and RELM gamma, which exhibit significant differences in structure, distribution, and function. The expression of RELMs is regulated by various signaling molecules, such as IL-4, IL-13, and their receptors. RELMs proteins are involved in a wide range of physiological and pathological processes, and participate in the progression of numerous diseases. Meanwhile, RELMs can serve as biomarkers, risk predictors, and therapeutic targets for these diseases, providing novel targets or strategies for their treatment and prevention.
Resistin-like molecules (RELMs) are highly cysteine-rich proteins, including RELM alpha, RELM beta, Resistin, and RELM gamma. However, RELMs exhibit significant differences in structure, distribution, and function. The expression of RELMs is regulated by various signaling molecules, such as IL-4, IL-13, and their receptors. In addition, RELMs can mediate numerous signaling pathways, including HMGB1/RAGE, IL-4/IL-4R alpha, PI3K/Akt/mTOR signaling pathways, and so on. RELMs proteins are involved in wide range of physiological and pathological processes, including inflammatory response, cell proliferation, glucose metabolism, barrier defense, etc., and participate in the progression of numerous diseases such as lung diseases, intestinal diseases, cardiovascular diseases, and cancers. Meanwhile, RELMs can serve as biomarkers, risk predictors, and therapeutic targets for these diseases. An in-depth understanding of the role of RELMs may provide novel targets or strategies for the treatment and prevention of related diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据